Clinico-Epidemiological Profile and Treatment Pattern of Vitiligo in Selected Dermatological Clinics of Mekelle City, Northern Ethiopia

Background Vitiligo is not a well-studied disease in Ethiopia. Therefore, this study assessed its clinico-epidemiological profile and treatment patterns. Methods An institutional-based cross-sectional study was conducted in conveniently selected dermatologic clinics of Mekelle city, Ethiopia. A two-phased study was conducted, in which the first was to determine prevalence of vitiligo while the second phase was to describe the clinico-epidemiological profile and treatment pattern of vitiligo. Four-hundred three randomly selected dermatological patients were included in the first phase study. The second phase study included vitiligo cases from the first phase study and additional vitiligo cases found in a two months period prospective study. Results Of the 403 randomly selected dermatological patients who presented in the year 2017 to 2019, the prevalence of vitiligo was 13.15%. Of the 79 cases with vitiligo, nearly two-thirds (50, 63.3%) were males with five years as the median age at onset of the disease. Positive family history of vitiligo was recorded in about one-third (25, 31.6%) of the cases. Limbs (48, 44.5%) followed by the head and neck (26, 24%) were the most commonly affected parts of the body at the onset of the disease. The most prevalent clinical form of vitiligo was vulgaris (39.2%) followed by the focal type (26.6%). Emotional upset (24, 33.8%) and physical traumas (23, 32.4%) were the frequently reported triggering factors of vitiligo. Three-fourths (75.5%) of the cases had prescriptions of topical corticosteroids, and 24.5% of them had prescriptions of sun screen lotion. Conclusion The prevalence of vitiligo was found to be high. The clinico-epidemiological profile of vitiligo in Ethiopia was similar with that found globally. However, treatment options of vitiligo were very limited in Ethiopia.

[1]  T. Cestari,et al.  Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Brazilian Portuguese* , 2015, Anais brasileiros de dermatologia.

[2]  P. Raghavan,et al.  Myths and Facts about Vitiligo: An Epidemiological Study , 2015, Indian journal of pharmaceutical sciences.

[3]  P. Ramakrishna,et al.  Psychiatric Morbidity and Quality of Life in Vitiligo Patients , 2014, Indian journal of psychological medicine.

[4]  S. Agarwal,et al.  Profile of Vitiligo in Kumaun Region of Uttarakhand, India , 2014, Indian journal of dermatology.

[5]  N. Silverberg Pediatric vitiligo. , 2014, Pediatric clinics of North America.

[6]  T. Jouary,et al.  Development and validation of the K‐VSCOR for scoring Koebner's phenomenon in vitiligo/non‐segmental vitiligo , 2013, Pigment cell & melanoma research.

[7]  S. Farajzadeh,et al.  Clinical characteristics of late-onset vitiligo in an Iranian population , 2012 .

[8]  D. Shankar,et al.  Clinical patterns of vitiligo and its associated co morbidities: A prospective controlled cross-sectional study in South India , 2012, Indian dermatology online journal.

[9]  R. Reghu,et al.  EPIDEMIOLOGICAL PROFILE AND TREATMENT PATTERN OF VITILIGO IN A TERTIARY CARE TEACHING HOSPITAL , 2011 .

[10]  K. Alghamdi Beliefs and perceptions of Arab vitiligo patients regarding their condition , 2010, International journal of dermatology.

[11]  B. N. Akay,et al.  Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[12]  I. George,et al.  Vitiligo: a hospital-based study in Southern Nigeria , 2010 .

[13]  A. Osman,et al.  The Socio-demography and Clinical Profile of Vitiligo in Sudan. , 2009 .

[14]  M. Hamdaoui,et al.  Profile of vitiligo in the south of Tunisia , 2008, International journal of dermatology.

[15]  A. A. Robaee Assessment of quality of life in Saudi patients with vitiligo in a medical school in Qassim province, Saudi Arabia , 2007 .

[16]  N. Gavalas,et al.  Autoimmunity as an aetiological factor in vitiligo , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[17]  Y. H. Kumar,et al.  Vitiligo: a part of a systemic autoimmune process. , 2007, Indian journal of dermatology, venereology and leprology.

[18]  W. Du,et al.  Clinical profiles of vitiligo in China: an analysis of 3742 patients , 2005, Clinical and experimental dermatology.

[19]  Y. Won,et al.  A Clinical Study of 265 Patients with Vitiligo in the Gwangju Chonnam Province , 2005 .

[20]  F. Mayoral,et al.  Repigmentation of Vitiligo with Pimecrolimus Cream: A Case Report , 2003, Dermatology.

[21]  S. Prćić,et al.  [Vitiligo in childhood]. , 2002, Medicinski pregled.

[22]  D. Thappa,et al.  Clinical predictors of outcome in vitiligo. , 2002, Indian journal of dermatology, venereology and leprology.

[23]  S. Handa,et al.  Vitiligo: Clinical Findings in 1436 Patients , 1999, The Journal of dermatology.

[24]  Malkit Singh,et al.  Clinical Pattern of Vitiligo in Libya , 1985, International journal of dermatology.